Thomas J. Jaquin

434 total citations
9 papers, 206 citations indexed

About

Thomas J. Jaquin is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy. According to data from OpenAlex, Thomas J. Jaquin has authored 9 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology and Allergy. Recurrent topics in Thomas J. Jaquin's work include Cell Adhesion Molecules Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (4 papers). Thomas J. Jaquin is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (4 papers). Thomas J. Jaquin collaborates with scholars based in United Kingdom, Germany and United States. Thomas J. Jaquin's co-authors include Shane A. Olwill, Julie A. Gormley, Christopher J. Scott, James A. Johnston, Roberta E. Burden, Donna M. Small, Shauna Hegarty, Derek J. Quinn, Brian Walker and Roy Bicknell and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Thomas J. Jaquin

9 papers receiving 206 citations

Peers

Countries citing papers authored by Thomas J. Jaquin

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Jaquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Jaquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Jaquin more than expected).

Fields of papers citing papers by Thomas J. Jaquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Jaquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Jaquin. The network helps show where Thomas J. Jaquin may publish in the future.

Co-authorship network of co-authors of Thomas J. Jaquin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Jaquin. A scholar is included among the top collaborators of Thomas J. Jaquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Jaquin. Thomas J. Jaquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A new Anticalin protein for IL-23 inhibits non-type 2 allergen-driven mouse lung inflammation and airway hyperresponsiveness 2024 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Thayse R. Brüggemann, Nandini Krishnamoorthy, Matthias Hagner, Gabriele Matschiner, Thomas J. Jaquin, Luciana P. Tavares, Hong Yong Peh, Bruce D. Levy	2
2	Development of PRS-220, a potential best-in-class, inhaled CTGF/CCN2 inhibitor for the treatment of IPF 2021 ·(unknown), (unknown), Claudia Wurzenberger, (unknown), Cornelia Wurzenberger, Stefan Grüner, Janet K. Peper-Gabriel, Thomas J. Jaquin, (unknown), (unknown), Josef Prassler, Gabriele Matschiner, Shane A. Olwill	3
3	Abstract LB135: Simultaneous costimulatory T-cell engagement and checkpoint inhibition by PRS-344/S095012, a PD-L1/4-1BB bispecific compound for tumor localized activation of the immune system 2021 ·Cancer Research ·Aizea Morales‐Kastresana, (unknown), Janet K. Peper-Gabriel, Lucia Pattarini, (unknown), (unknown), (unknown), Birgit Bossenmaier, Alix Scholer‐Dahirel, Thomas J. Jaquin, Catherine Gallou, Véronique Blanc, Christine Rothe, Shane A. Olwill	1
4	Abstract 3673: Preclinical toxicology and pharmacology for the 4-1BB/HER2 bispecific PRS-343: A first-in-class costimulatory T cell engager 2017 ·Cancer Research ·Marlon J. Hinner, (unknown), Thomas J. Jaquin, Sven Berger, Manuela Dürr, Corinna Schlosser, (unknown), Christine Rothe, Louis A. Matis, Shane A. Olwill	2
5	Abstract B016: Costimulatory T-cell engagement by PRS-343, a CD137 (4-1BB)/HER2 bispecific, leads to tumor growth inhibition and TIL expansion in humanized mouse model 2016 ·Cancer Immunology Research ·Marlon J. Hinner, (unknown), Corinna Schlosser, Thomas J. Jaquin, (unknown), Sven Berger, Alexander Wiedenmann, Gabriele Matschiner, Julia Schüler, Ulrich Moebius, Christine Rothe, Shane A. Olwill	1
6	Costimulatory T-cell engagement by PRS-343, a CD137 (4-1BB)/HER2 bispecific, leads to tumor growth inhibition and TIL expansion in a humanized mouse model 2016 ·European Journal of Cancer ·Marlon J. Hinner, (unknown), Corinna Schlosser, Thomas J. Jaquin, (unknown), Sven Berger, Alexander Wiedenmann, Gabriele Matschiner, Julia Schüler, Ulrich Moebius, Christine Rothe, Shane A. Olwill	9
7	Inhibition of Cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas 2011 ·Biochimie ·Roberta E. Burden, Julie A. Gormley, (unknown), (unknown), Hang Fai Kwok, (unknown), (unknown), Thomas J. Jaquin, James A. Johnston, Christopher J. Scott, Shane A. Olwill	47
8	Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF 2010 ·PLoS ONE ·(unknown), (unknown), Roberta E. Burden, Julie A. Gormley, Thomas J. Jaquin, (unknown), Donna M. Small, Roy Bicknell, James A. Johnston, Christopher J. Scott, Shane A. Olwill	54
9	Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis 2009 ·Clinical Cancer Research ·Roberta E. Burden, Julie A. Gormley, Thomas J. Jaquin, Donna M. Small, Derek J. Quinn, Shauna Hegarty, (unknown), Brian Walker, James A. Johnston, Shane A. Olwill, Christopher J. Scott	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact